* Ultralife Corp ULBI.OQ ULBI.O is expected to show a
rise in
quarterly revenue when it reports results on November 8 for the
period ending September 30 2024
* The Newark New York New York-based company is expected to
report a 8.9% increase in revenue to $43 million from $39.49
million a year ago, according to the estimate from one analyst,
based on LSEG data.
* LSEG's mean analyst estimate for Ultralife Corp is for
earnings
of 21 cents per share.
* The one available analyst rating on the shares is "buy".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Ultralife
Corp is
$14.00, above its last closing price of $9.02.
This summary was machine generated November 6 at 14:06 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)